dockets: FDA-2025-P-6315

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

This data as json

id	agency_id	title	docket_type	last_modified	object_id
FDA-2025-P-6315	FDA	Request that the FDA ensure that applications submitted under 505(j) and 505(b)(2) that rely on LEQVIO include data necessary to show that a proposed product is pharmaceutically equivalent and can be expected to have the same clinical effect and safety profile as LEQVIO when administered to patients under the conditions specified in the labeling	Nonrulemaking	2026-05-12T14:26:15Z	0b000064b90883fa

Links from other tables